Is renal cryoablation becoming an effective alternative to partial nephrectomy?

Similar documents
RAPN. in T1b Renal Masses? A. Mottrie. G. Denaeyer, P. Schatteman, G. Novara

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys?

John Fitzpatrick Memorial Lecture. John Fitzpatrick Memorial lecture

Percutaneous ablation of renal cell carcinoma. Where do we stand now? Sanja Stojanović, Spasić Aleksandar

Focal Ablative Therapies for Kidney Cancer

ablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine

What is the role of partial nephrectomy in the context of active surveillance and renal ablation?

Less is more: Merit of Non-Surgical Management of Kidney Cancer

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer

Indications For Partial

Vincenzo Ficarra. Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine

Renal Mass Biopsy: Needed Now More than Ever

Renal Mass Biopsy Should be Used for Most SRM - PRO

Challenges in RCC surgery. Treatment Goals. Surgical challenges. Management options in VHL associated RCCs

Freeze, Fry or Cut. Jennifer A. Linehan, MD Associate Professor Urologic Oncology John Wayne Cancer Institute 2/9/2018

Contemporary Role of Renal Mass Biopsy

Percutaneous Renal Cryoablation After Partial Nephrectomy: Technical Feasibility, Complications and Outcomes

Patient Selection for Ablative Therapies. Adrian D Joyce Leeds UK

RENAL CANCER. Dr. Giandomenico Roviello. Oncologia Medica Ospedale San Donato Arezzo

Vincenzo Ficarra 1,2,3. Associate Editor BJU International

Management of Locally Reccurent Renal Cell Carcinoma. Jose A. Karam, MD, FACS Assistant Professor Department of Urology

Section Activity Activity Description Details Reference(s)

WHAT IS THE ROLE OF ACTIVE SURVEILLANCE

PerCryo Ablation CLINICAL DATA REVIEW 2015

Guidelines on Renal Cell

Who are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav

How I do it: percutaneous radiofrequency ablation (RFA) Igor Sorokin, MD 1 Murthy Chamarthy, MD, 2 Jeffrey A. Cadeddu, MD 1,2 1

EUROPEAN UROLOGY 61 (2012)

Salvage surgery after energy ablation for renal masses

Canadian Guidelines for Management of the Small Renal Mass (SRM)

Presentation of Cases /Audience Voting/Panel/Discussion

Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic

Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience

Surgery of Renal Cell Carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute

GUIDELINES ON RENAL CELL CARCINOMA

Hyperechoic renal masses

Usefulness of R.E.N.A.L. Nephrometry Scoring System for Predicting Outcomes and Complications of Percutaneous Ablation of 751 Renal Tumors

Multidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute

Complications in robotic surgery!! Review of the literature! RALP, RAPN and RARC!

oth percutaneous radiofrequency ablation (RFA) and cryoablation have shown favorable local tumor

AUA Guidelines Renal Mass and Localized Kidney Cancer

Surgical Management of Renal Cancer. David Nicol Consultant Urologist

Damian Dupuy, MD. Image Guided Intervention (IGI) Studies 10:25 11:05 AM

Minimal invasive treatment of small renal masses

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Complex case Presentations

The Incidental Renal lesion

ONCOLOGIC PERCUTANEOUS INTERVENTION: 2015 UPDATE HANH VU NGHIEM, MD OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE

Renal cryoablation of small renal masses: A Korea University experience

Radiofrequency ablation of kidney tumours and lesions: A review of the literature

Comparison of radiographic and pathologic sizes of renal tumors

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Small Renal Mass Guidelines. Clif Vestal, MD USMD Arlington, Texas

ACTIVE SURVEILLANCE FOR RENAL MASSES: Where are we in 2016?

Renal biopsy is mandatory for every small renal mass

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma

Percutaneous cryoablation of lung tumors

Mahrad Paymani, MD Lake Medical Imaging

were reduced by the cost of probe. With a median follow-up of 20 months there was no difference in oncological outcome.

TITLE: Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline

Bilateral Renal Angiomyolipomas with Invasion of the Renal Vein: A Case Report

SBRT for lung metastases: Case report

Management, pathology and outcomes of Bosniak category IIF and III cystic renal lesions

UroCryo Ablation CLINICAL DATA REVIEW HealthTronics, Inc. All rights reserved.

Use of microwave ablation in the treatment of patients with multiple primary malignant tumors

Radiofrequency ablation combined with conventional radiotherapy: a treatment option for patients with medically inoperable lung cancer

GUIDELINES ON RENAL CELL CANCER

Questions to ask before you have a kidney removed for kidney cancer

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Prospective multi-center study of oncologic outcomes of robot-assisted partial nephrectomy for pt1 renal cell carcinoma

Directness Consistency Precision Reporting Bias

Renal Masses in Patients with Known Extrarenal Primary Primary Cancer Primary Primary n Met Mets s RCC Beni L mphoma Lung Breast Others

Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Prostate, or Dermatologic Tumors. Description

James Cassuto, MS IV. Shekher Maddineni, MD Samuel McCabe, MD Vascular and Interventional Radiology

PerCryo Ablation CLINICAL DATA REVIEW 2016

SAMPLING OF POST NEPHRECTOMY CANCER CARE (5)

St. Dominic s Annual Cancer Report Outcomes

Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate, or Dermatologic Tumors

Over 35,000 new cases of renal

Robotic-assisted ipsilateral adrenalectomy after robotic-assisted partial nephrectomy: a case report

Clinical Study The Role of Pathology in Small Renal Mass Laparoscopic Cryoablation

Lymphadenectomy in RCC: Yes, No, Clinical Trial?

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Florida Cancer Specialist & Research Institute, Sebastian and Vero Beach, Fl, USA 3

ROBOTIC VS OPEN RADICAL CYSTECTOMY

The Incidental Renal Mass in the Primary Care Setting

Clinical/Surgical trials that will change my practice

BJUI. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy

MEDICAL POLICY SUBJECT: CRYOSURGICAL TUMOR ABLATION. POLICY NUMBER: CATEGORY: Technology Assessment

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano

Indications for biopsy and the current status of focal therapy for renal tumours

The Surgical Management of RCC

Appendix 4 Urology Care Pathways

RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management

Oncourology COMPLICATIONS OF PARTIAL NEPHRECTOMY AT OPERATIVE TREATMENT OF RENAL CELL CARCINOMA

Patient Selection for Surgery in RCC with Thrombus. E. Jason Abel, M.D.

3.1 Investigations for Patients Presenting with Haematuria Table 1

Debate: Lymphadenectomy is Important in mrcc, CON P. Mulder, M.D., Ph.D. JJ. Patard, MD, Ph.D.

Patient and nonradiographic tumor characteristics predicting lipid-poor angiomyolipoma in small renal masses: Introducing the BEARS index

Transcription:

Is renal cryoablation becoming an effective alternative to partial nephrectomy? J GARNON 1, G TSOUMAKIDOU 1, H LANG 2, A GANGI 1 1 department of interventional radiology 2 department of urology University Hospital of Strasbourg

woman 60 y.o 8 mm RCC no CI to surgery => man 55 y.o 20 mm RCC no CI to surgery =>

1.Diagnostic 2.R0 resection 3.No complication 4.No recurrence

ANATOMOPATHOLOGY malignant benign RCC other Overall accuracy: > 90% (one biopsy) 99% (rebiopsy) type Fuhrman grading RCC subtype: identification in 93% accuracy > 90% Fuhrmann grade: accuracy variable difference = 1 grade

CT-scan

CT-scan

MRI

MRI

hydrodissection carbodissection

Ultrasound +/- CT ++ MRI +++

Ultrasound +/- CT ++ MRI +++

No histological analysis after cryo => imaging (MRI+++) COMPLICATIONS? COMPLETE ABLATION? RECURRENT DISEASE? treatment 24h 1 month 1 year death 1. lack of enhancement 2. halo sign 3. retraction of the scar M3 M6 M12

Percutaneous cryoablation of solitary sporadic renal cell carcinomas. Schmit et al. BJU int. 2012 Technical success = 99% Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients. Schmit et al. J Endourol. 2010 Technical success = 97% Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. Buy et al. AJR 2013 Technical success = 94% Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients. Breen et al. BJU int. 2013 Technical success = 92%

less complications after cryo than PN main complication: bleeding Percutaneous cryoablation of solitary sporadic renal cell carcinomas. Schmit et al. BJU int. 2012 complication rate (T1a) = 4% complication rate (T1b) = 15% Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. Buy et al. AJR 2013 complication rate = 4% more frequent for T1b Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients. Breen et al. BJU int. 2013 complication rate = 4,6% more frequent for T1b

percutaneous injection of thrombin

selective embolisation

coagulation with the cryoprobes

49 y.o man No CI to surgery 1,8cm RCC A. Percutaneous cryoablation is not technically feasible => PN B. Percutaneous cryoablation is feasible but more risky than surgery in this case (pyelo-ureteral junction) => PN C. Percutaneous cryoablation can be proposed to the patient as an alternative to PN => PN or cryo D. Percutaneous cryoablation = active surveillance in this case

134 RCC Mean size: 2,8cm 86% T1a RCC 5 years overall survival: 97,8% 5 years cancer specific survival: 100% Efficacy:

PN vs percutaneous ablation 1424 patients (1057 PN, 367 ablation) 3-years local recurrence free survival: - PN: 98% - Cryo: 98% - RFA: 98% Overall survival:

Problem: few studies with long follow-up Laparoscopic renal cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal masses: a systematic review and meta-analysis of comparative studies. Tang et al. J Laparoendosc Adv Surg Tech A. 2014 Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. Klatte et al. J Urol. 2014 PN > LCA laparoscopic = percutaneous?

Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Technique Considerations, Safety, and Local Tumor Control. Atwell et al. JVIR 2015 Technical failure = 1/46 complication rate = 15,6% 348 PN / 48 percutaneous ablation 3 years local recurrence free survival: - PN: 96% (229 patients) - Cryo: 97% (13 patients)

Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. Buy et al. AJR 2013 worse outcome with T1b tumors (more recurrences and more complications) 30% of incomplete treatments and local recurrences

is renal cryoablation an effective alternative to partial nephrectomy? T1a Almost all tumors may be ablated with a percutaneous approach Oncological results seem almost as good as those obtained with PN BUT Few studies with large cohorts of patients and long follow-up Renal cryoablation versus robot-assisted partial nephrectomy: Washington University longterm experience. Tanagho et al. J Endourol 2013 «While RAPN offers improved DFS, for those willing to undergo close postoperative monitoring and accept the potential need for re-treatment of recurrent disease, cryoablation offers excellent long-term CSS»

is renal cryoablation an effective alternative to partial nephrectomy? T1b High rate of complications High rate of incomplete ablations/recurrent disease => cryoablation only for non surgical candidates

Team work